PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives

Overexpression of urokinase-type plasminogen activator receptors (uPAR) represents an important biomarker for aggressiveness in most common malignant diseases, including prostate cancer (PC). Accordingly, uPAR expression either assessed directly in malignant PC tissue or assessed directly in plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Skovgaard, Dorthe, Persson, Morten, Kjaer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118403/
https://www.ncbi.nlm.nih.gov/pubmed/27933281
http://dx.doi.org/10.1007/s40336-016-0197-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118403/
https://www.ncbi.nlm.nih.gov/pubmed/27933281
http://dx.doi.org/10.1007/s40336-016-0197-4

Ejemplares similares